Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s diseaseClaudia P. González-Hunt, Laurie H. Sanders|Scientific Reports|2020Cited by 43
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damageNicholas Pena, Laurie H. Sanders|npj Parkinson s Disease|2024Cited by 27
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damageNicholas Pena, Laurie H. Sanders|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 5
Parkinson’s disease linked LRRK2 G2019S drives oxidative nuclear DNA damage and PARP1 hyperactive signalingLaurie H. Sanders|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0
Rab12 is a regulator of mitophagy and mitochondrial homeostasisTara Richbourg, Laurie H. Sanders|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0